LAB HOLDINGS ($LH) posted quarterly earnings results for Q4 2025 on Tuesday, February 17th. The company reported earnings of $4.07 per share, beating estimates of $4.06 by $0.01. The company also reported revenue of $3,515,800,000, missing estimates of $3,665,011,992 by $-149,211,992.
You can see Quiver Quantitative's $LH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LAB HOLDINGS Insider Trading Activity
LAB HOLDINGS insiders have traded $LH stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $LH stock by insiders over the last 6 months:
- ADAM H SCHECHTER (President & CEO) has made 0 purchases and 2 sales selling 11,018 shares for an estimated $3,009,034.
- RICHELLE P PARHAM sold 7,009 shares for an estimated $1,782,273
- JONATHAN C MELTZER (EVP, Operations) has made 0 purchases and 3 sales selling 266 shares for an estimated $74,701.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LAB HOLDINGS Hedge Fund Activity
We have seen 398 institutional investors add shares of LAB HOLDINGS stock to their portfolio, and 524 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VICTORY CAPITAL MANAGEMENT INC added 2,719,475 shares (+103.1%) to their portfolio in Q4 2025, for an estimated $682,261,888
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,658,379 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $666,934,123
- BOSTON PARTNERS added 1,913,695 shares (+inf%) to their portfolio in Q4 2025, for an estimated $480,107,801
- BLACKROCK, INC. removed 1,584,752 shares (-19.5%) from their portfolio in Q4 2025, for an estimated $397,582,581
- BANK OF NEW YORK MELLON CORP removed 1,197,606 shares (-67.6%) from their portfolio in Q4 2025, for an estimated $300,455,393
- NORDEA INVESTMENT MANAGEMENT AB removed 553,253 shares (-36.4%) from their portfolio in Q4 2025, for an estimated $138,800,112
- LAZARD ASSET MANAGEMENT LLC removed 505,913 shares (-51.1%) from their portfolio in Q3 2025, for an estimated $145,227,385
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LAB HOLDINGS Congressional Stock Trading
Members of Congress have traded $LH stock 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LH stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 4 times. They made 4 purchases worth up to $60,000 on 01/28, 11/17, 10/31, 10/29 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
LAB HOLDINGS Analyst Ratings
Wall Street analysts have issued reports on $LH in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 11/07/2025
- UBS issued a "Buy" rating on 10/29/2025
- Mizuho issued a "Outperform" rating on 10/17/2025
- Evercore ISI Group issued a "Outperform" rating on 10/03/2025
To track analyst ratings and price targets for LAB HOLDINGS, check out Quiver Quantitative's $LH forecast page.
LAB HOLDINGS Price Targets
Multiple analysts have issued price targets for $LH recently. We have seen 5 analysts offer price targets for $LH in the last 6 months, with a median target of $319.0.
Here are some recent targets:
- Lisa Gill from JP Morgan set a target price of $319.0 on 02/06/2026
- Kevin Caliendo from UBS set a target price of $320.0 on 10/29/2025
- Ann Hynes from Mizuho set a target price of $320.0 on 10/17/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $305.0 on 10/03/2025
- Jack Meehan from Barclays set a target price of $290.0 on 10/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
